Dose dependent slurred speech and laryngopharyngeal dysesthesia due to oxaliplatin.

Diana VargheseRenita CastelinoVijay SimhaManjunath Nookala KrishnamurthyVikram Gota

Published in: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners (2022)

Occurrence of laryngopharyngeal dysesthesia due to oxaliplatin does not warrant drug withdrawal, dose titration can be helpful, thereby preventing the drug withdrawal for the patient management.

Keyphrases

risk assessment
case report